Search Results - Kay-Gunnar Stubenrauch

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors

    Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of s... by Marion Subklewe, Christian Klein, Sebastian Kobold, Pablo Umana, Stefan Endres, Christian Jost, Mohamed-Reda Benmebarek, Anne Freimoser-Grundschober, Sophia Stock, Anna-Kristina Kluever, Diana Darowski, Kay-Gunnar Stubenrauch, Joerg Benz, Ekkehard Moessner

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure

    Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure by Gregor P. Lotz, Achim Lutz, Meret Martin-Facklam, Andre Hansbauer, Eginhard Schick, Ekkehard Moessner, Michael Antony, Thomas Stuchly, Maria Viert, Ralf J. Hosse, Anne Freimoser-Grundschober, Christian Klein, Martin Schäfer, Mirko Ritter, Kay-Gunnar Stubenrauch

    Published 2024-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper

    Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper by Tong-yuan Yang, Manuela Braun, Wibke Lembke, Fraser McBlane, John Kamerud, Stephen DeWall, Edit Tarcsa, Xiaodong Fang, Lena Hofer, Uma Kavita, Vijay V. Upreti, Swati Gupta, LiNa Loo, Alison J. Johnson, Rakesh Kantilal Chandode, Kay-Gunnar Stubenrauch, Maya Vinzing, Cindy Q. Xia, Vibha Jawa

    Published 2022-09-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody

    Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody by Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, Wolfgang F. Richter, Gregor Jordan, Jan Eckmann, Carina Hage, Valeria Nicolini, Anne Freimoser-Grundschober, Mirko Ritter, Matthias E. Lauer, Henning Stahlberg, Philippe Ringler, Jigar Patel, Eric Sullivan, Sandra Grau-Richards, Stefan Endres, Sebastian Kobold, Pablo Umaña, Peter Brünker, Christian Klein

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: